Following are newly released NCI research funding opportunities:

Exfoliated Cells and Circulating DNA in Cancer Detection and Diagnosis
Announcement Number: RFA-CA-07-027
Letter of Intent Receipt Dates: Aug. 26 and Dec. 29, 2006; April 23, 2007.
Application Receipt Dates: Sept. 26, 2006; Jan. 29 and May 23, 2007.

This is a renewal of RFA-CA-06-001 and will use the R43/R44 award mechanism. For more information, see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=3517. Inquiries: Dr. Padma Maruvada - maruvadp@mail.nih.gov

Exfoliated Cells and Circulating DNA in Cancer Detection and Diagnosis
Announcement Number: RFA-CA-07-028
Letter of Intent Receipt Dates: Aug. 26 and Dec. 29, 2006; April 23, 2007.
Application Receipt Dates: Sept. 26, 2006; Jan. 29 and May 23, 2007.

This is a renewal of RFA-CA-06-001 and will use the R41/R42 award mechanism. For more information, see http://cri.nci.nih.gov/4abst.cfm?initiativeparfa_id=3518. Inquiries: Dr. Padma Maruvada - maruvadp@mail.nih.gov

For comprehensive information about NCI funding priorities and opportunities, go to http://www.cancer.gov/researchfunding.

The NIH Roadmap for Medical Research Funding provides a framework of the priorities NIH must address to optimize its research portfolio. It identifies the most compelling opportunities in three main areas: new pathways to discovery, research teams of the future, and re-engineering the clinical research enterprise. For information on additional Roadmap funding opportunities, go to http://nihroadmap.nih.gov.